SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational Phase III clinical trials of its lead product candidate, the ...

Adults with obesity and type 2 diabetes who underwent bariatric surgery had greater decreases in HbA1c and body weight than ...

Concept Medical has enrolled the first patients in the STARS DAPT global trial evaluating its polymer-free Abl ...

Across all income levels, bariatric surgery resulted in better diabetes control than GLP-1s or similar medications, a study ...

Approved as Quviviq in Japan, daridorexant is being marketed through a partnership between Nxera and Shionogi.

FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical ...

Creatine supplements are used to boost athletic performance and may have benefits for women in perimenopause. Potential ...

Brainomix, a global leader and pioneer of AI-powered imaging tools in lung fibrosis and stroke, today announced it was ...

Corvus Pharmaceuticals (NASDAQ:CRVS) shares surged 48% on Tuesday after the company released positive findings from a Phase 1 clinical study of its oral drug candidate soquelitinib in atopic ...

The MarketWatch News Department was not involved in the creation of this content.-- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimob ...

A large-scale clinical trial has determined that a specific brain stimulation device, previously cleared by regulators for ...

High-dose influenza vaccines may lower serious hospitalization rates in older adults, particularly those with diabetes, ...